RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @TeamPostX: Multiple early factors anticipate post-acute COVID-19 sequelae @PutrinoLab thank you https://t.co/xTHIWNdUrR
@szaktuell State of the art: framework understand heterogeneity of “long COVID“, rich resource for investigating biological factors which can potentially be utilized to guide interventional trials to treat and prevent post-acute COVID-19 symptoms. https://
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
Multiple early factors anticipate post-acute COVID-19 sequelae @PutrinoLab thank you https://t.co/xTHIWNdUrR
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISGlNd by @VirusesImmunity @PutrinoLab https://t.co/n1hxFYd4Fk by @LabHeath But some of these antibodies appear to be protective 👇 htt
RT @bar1star: BMIの中央値が30の集団で、メトホルミン投与がLong-COVIDの発生率を減らしたというプレプリント論文が話題。 2型糖尿病がPASC(≒Long-COVID)の危険因子という知見も蓄積しており、直感的には合致する結果。 一方で、標準体型の人…
あとでよく読んでみたいと思います。 https://t.co/n7jlRS7jdZ
RT @bar1star: BMIの中央値が30の集団で、メトホルミン投与がLong-COVIDの発生率を減らしたというプレプリント論文が話題。 2型糖尿病がPASC(≒Long-COVID)の危険因子という知見も蓄積しており、直感的には合致する結果。 一方で、標準体型の人…
RT @bar1star: BMIの中央値が30の集団で、メトホルミン投与がLong-COVIDの発生率を減らしたというプレプリント論文が話題。 2型糖尿病がPASC(≒Long-COVID)の危険因子という知見も蓄積しており、直感的には合致する結果。 一方で、標準体型の人…
RT @bar1star: BMIの中央値が30の集団で、メトホルミン投与がLong-COVIDの発生率を減らしたというプレプリント論文が話題。 2型糖尿病がPASC(≒Long-COVID)の危険因子という知見も蓄積しており、直感的には合致する結果。 一方で、標準体型の人…
RT @bar1star: BMIの中央値が30の集団で、メトホルミン投与がLong-COVIDの発生率を減らしたというプレプリント論文が話題。 2型糖尿病がPASC(≒Long-COVID)の危険因子という知見も蓄積しており、直感的には合致する結果。 一方で、標準体型の人…
RT @bar1star: BMIの中央値が30の集団で、メトホルミン投与がLong-COVIDの発生率を減らしたというプレプリント論文が話題。 2型糖尿病がPASC(≒Long-COVID)の危険因子という知見も蓄積しており、直感的には合致する結果。 一方で、標準体型の人…
RT @bar1star: BMIの中央値が30の集団で、メトホルミン投与がLong-COVIDの発生率を減らしたというプレプリント論文が話題。 2型糖尿病がPASC(≒Long-COVID)の危険因子という知見も蓄積しており、直感的には合致する結果。 一方で、標準体型の人…
RT @bar1star: BMIの中央値が30の集団で、メトホルミン投与がLong-COVIDの発生率を減らしたというプレプリント論文が話題。 2型糖尿病がPASC(≒Long-COVID)の危険因子という知見も蓄積しており、直感的には合致する結果。 一方で、標準体型の人…
RT @bar1star: BMIの中央値が30の集団で、メトホルミン投与がLong-COVIDの発生率を減らしたというプレプリント論文が話題。 2型糖尿病がPASC(≒Long-COVID)の危険因子という知見も蓄積しており、直感的には合致する結果。 一方で、標準体型の人…
RT @bar1star: BMIの中央値が30の集団で、メトホルミン投与がLong-COVIDの発生率を減らしたというプレプリント論文が話題。 2型糖尿病がPASC(≒Long-COVID)の危険因子という知見も蓄積しており、直感的には合致する結果。 一方で、標準体型の人…
RT @bar1star: BMIの中央値が30の集団で、メトホルミン投与がLong-COVIDの発生率を減らしたというプレプリント論文が話題。 2型糖尿病がPASC(≒Long-COVID)の危険因子という知見も蓄積しており、直感的には合致する結果。 一方で、標準体型の人…
BMIの中央値が30の集団で、メトホルミン投与がLong-COVIDの発生率を減らしたというプレプリント論文が話題。 2型糖尿病がPASC(≒Long-COVID)の危険因子という知見も蓄積しており、直感的には合致する結果。 一方で、標準体型の人において"万能薬"扱いするのも良くなさそう。 https://t.co/DPiwaDFOHX
@USBornNRaised @AnonymousOrwell I know Post-Covid conditions in patients vary, but the experts are clearly working on that. I'm no expert, so not in a position to refute the integrity of the EU blood tests for #LongCovid; I trust the research of Medical
@Dave99117584 @VGrubsky @TJGroeneveld94 Just so you know, immunity theft is being widely misrepresented. However you want to call it, there's plenty of evidence of immune dysregulation after infection, acquired lymphocytopenia etc. This thread (from last
RT @carpe_diem0820: 抗核自己抗体がCOVID-19罹患から回復後12カ月後に検出され、サイトカイン、炎症マーカー、Long COVID症状と関連 一方、罹患前の自己抗体や接種歴は不明で因果関係は評価できず Circulating anti-nuclear…
RT @carpe_diem0820: 抗核自己抗体がCOVID-19罹患から回復後12カ月後に検出され、サイトカイン、炎症マーカー、Long COVID症状と関連 一方、罹患前の自己抗体や接種歴は不明で因果関係は評価できず Circulating anti-nuclear…
RT @carpe_diem0820: 抗核自己抗体がCOVID-19罹患から回復後12カ月後に検出され、サイトカイン、炎症マーカー、Long COVID症状と関連 一方、罹患前の自己抗体や接種歴は不明で因果関係は評価できず Circulating anti-nuclear…
RT @carpe_diem0820: 抗核自己抗体がCOVID-19罹患から回復後12カ月後に検出され、サイトカイン、炎症マーカー、Long COVID症状と関連 一方、罹患前の自己抗体や接種歴は不明で因果関係は評価できず Circulating anti-nuclear…
抗核自己抗体がCOVID-19罹患から回復後12カ月後に検出され、サイトカイン、炎症マーカー、Long COVID症状と関連 一方、罹患前の自己抗体や接種歴は不明で因果関係は評価できず Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms https://t.co/abTCWdtVh0 https://t.co/UgHanmMFQG
@Jean__Fisch @OmicronData Well it's been linked to both severity and viral load: https://t.co/96QWyY7uZj So I'm assuming immunocompromised trend to be more susceptible to that (also because I believe viral persistence is the most likely driver of symptoms
@leanhealth EBV bereits Jan 22 auffällig https://t.co/kbx0uodf3d soweit ich sehe sogar vor Iwasaki?
@BreezerGalway @jneill @Saffiya_Khan1 @ShamezLadhani @UKHSA I’ll throw this in the mix claiming 31%-69% develop PASC. Wonder when the claim will reach 100%. https://t.co/yYGnQgXVIF
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @drkaseyholland: Reactivated Epstein-Barr virus is being considered as a marker for long haul Covid-19. When EBV reactivated it is a sig…
RT @drkaseyholland: Reactivated Epstein-Barr virus is being considered as a marker for long haul Covid-19. When EBV reactivated it is a sig…
Reactivated Epstein-Barr virus is being considered as a marker for long haul Covid-19. When EBV reactivated it is a sign that the body is burdened with oxidative stress. https://t.co/IpCloBl2DV
193/n istnieją też dowody, że kolejne reinfekcje u pacjentów z LC zwiększają podatność na ... kolejne reinfekcje https://t.co/E02RaE12tD
Badania wskazują na niski poziom kortyzolu we krwi u pacjentów z długim COVID w porównaniu z osobami kontrolnymi, ponad 1 rok do czasu trwania objawów 123/n https://t.co/E02RaE12tD
Stwierdzono, że wysoki poziom autoprzeciwciał w long COVID jest odwrotnie skorelowany z przeciwciałami o charakterze obronnym COVID-19, co sugeruje, że pacjenci z wysokim poziomem autoprzeciwciał mogą być bardziej narażeni na zakażenia przełomowe 62/n http
W wielu badaniach stwierdzono podwyższone poziomy autoprzeciwciał w LC 49/n https://t.co/E02RaE12tD https://t.co/2p36kRDPnU
Stwierdzono, że ekspansja cytotoksycznych limfocytów T jest związana z gastryczną prezentacją LC 45/n https://t.co/SpPwBKVsHe
RT @KonstPapakostas: Multiple early factors anticipate post-acute COVID-19 sequelae: Cell https://t.co/x7yr5Iq6tU
Multiple early factors anticipate post-acute COVID-19 sequelae: Cell https://t.co/x7yr5Iq6tU
Meget interessant: nogle typer immunresponser i senfølgepatienter som fx lave niveauer af antistoffer og eksistensen af autoantistoffer giver en øget risiko for reinfektion: https://t.co/8DsqFtNbVE
Long Covid患者において:T細胞の機能不全が継続している事を示す論文 https://t.co/nfFcDUwiGN 重症のCovid-19(新型コロナウイルス)において https://t.co/Hd3nM0NjsW EBVの再活性化を促進させる https://t.co/cdANCFt4GF 剖検時に肺の損傷で見られる https://t.co/735cylhB5d
When they're young might help predict whether a person contracts Long COVID: https://t.co/imdVbl5OAT. This article is interesting on our immune system: https://t.co/5CPZWN8TkY. On physical activity, long COVID patients relapse after exercise: https://t.co/
RT @DrWilliamMD: patients with neurological PASC exhibited slightly higher levels of anti-SARS-CoV-2 nucleocapsid protein IgG, whereas GI…
RT @DrWilliamMD: patients with neurological PASC exhibited slightly higher levels of anti-SARS-CoV-2 nucleocapsid protein IgG, whereas GI…
RT @DrWilliamMD: patients with neurological PASC exhibited slightly higher levels of anti-SARS-CoV-2 nucleocapsid protein IgG, whereas GI…
RT @KashPrime: Papers that show continuing dysfunction in T-cells: In Long Covid patients: https://t.co/xyQ5rfpXf7 In severe Covid-19 dise…
@gianlucac1 Da aggiungere una rilettura di questo https://t.co/VmjJRh4fDr
RT @KashPrime: Papers that show continuing dysfunction in T-cells: In Long Covid patients: https://t.co/xyQ5rfpXf7 In severe Covid-19 dise…
RT @KashPrime: Papers that show continuing dysfunction in T-cells: In Long Covid patients: https://t.co/xyQ5rfpXf7 In severe Covid-19 dise…